MediPharm Labs Corp. (TSX:LABS)
Canada · Delayed Price · Currency is CAD 0.0750
0.00 (0.00%)
Aug 10, 2026, 3:51 PM EST
MediPharm Labs Financials Overview
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 43.28 | 45.12 | 41.96 | 33.06 | 22.12 | 21.71 |
Revenue Growth | 0.66% | 7.54% | 26.92% | 49.49% | 1.87% | -39.71% |
Gross Profit Gross Profit Growth | 12.9 | 13.56 | 13.49 | 4.67 | -1.91 | -15.25 |
Operating Income Operating Income Growth | -8.91 | -8.44 | -10.81 | -18.25 | -29.53 | -48.92 |
Net Income Net Income Growth | -8.75 | -8.27 | -10.69 | -13.08 | -29.98 | -54.8 |
Earnings Per Share EPS Growth | -0.02 | -0.02 | -0.03 | -0.04 | -0.11 | -0.22 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Canada Canada Growth | 19.27 | 19.76 | 24.15 | 23.09 | 14.69 | 12.22 |
Australia Australia Growth | 9.69 | 10.72 | 8.83 | 5.39 | 2.61 | 4.3 |
Germany Germany Growth | 11.22 | 12.01 | 8.58 | 3.58 | 3.65 | 5.15 |
Other Other Growth | 3.11 | 2.64 | 0.41 | 1.01 | 1.17 | 0.04 |
Total Total Growth | 43.28 | 45.12 | 41.96 | 33.06 | 22.12 | 21.71 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 9.87 | 10.81 | 11.69 | 17.98 | 24.15 | 34.11 |
Total Debt Total Debt Growth | 0.02 | 0.2 | 0.39 | 2.3 | 0.63 | 0.22 |
Net Cash (Debt) Net Cash Growth | 9.85 | 10.61 | 11.3 | 15.69 | 23.51 | 33.89 |
Net Cash Growth | 18.39% | -6.17% | -27.95% | -33.29% | -30.63% | 2834.55% |
Net Cash Per Share Net Cash Per Share Growth | 0.02 | 0.03 | 0.03 | 0.04 | 0.08 | 0.14 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -3.32 | -5.5 | -4.86 | -12.34 | -16.07 | -13.21 |
Capital Expenditures CapEx Growth | -0.06 | -0.1 | -0.15 | -0.47 | -0.86 | -0.78 |
Free Cash Flow Free Cash Flow Growth | -3.38 | -5.6 | -5.02 | -12.81 | -16.93 | -14 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 29.80% | 30.06% | 32.15% | 14.12% | -8.65% | -70.22% |
Operating Margin | -20.58% | -18.70% | -25.76% | -55.21% | -133.53% | -225.31% |
Pretax Margin | -8.71% | -18.32% | -25.49% | -40.41% | -135.59% | -251.89% |
Profit Margin | -20.21% | -18.32% | -25.49% | -39.57% | -135.56% | -252.41% |
FCF Margin | -7.80% | -12.42% | -11.95% | -38.75% | -76.56% | -64.46% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 22.71 | 22.71 | 22.71 | 22.71 | 22.71 |
PS Ratio | 0.74 | 0.60 | 0.58 | 0.79 | 0.89 | 2.33 |